Related Experiment Video
Updated: Apr 23, 2026
09:39
A Platform of Anti-biofilm Assays Suited to the Exploration of Natural Compound Libraries
Published on: December 27, 2016
17.2K
Pharmacy Apps: a new frontier on the digital landscape?
Michael J Davies1, Matthew Collings2, William Fletcher2
1The School of Pharmacy and Biomolecular Sciences, Liverpool John Moores University (LJMU), Liverpool ( United Kingdom ). m.davies1@ljmu.ac.uk.
Pharmacy Practice
|September 23, 2014
Summary
UK pharmacists find mobile apps useful for patient consultations and education, but company policy and regulation barriers hinder current adoption. Future impact is anticipated as technology evolves.
Area of Science:
- Digital Health
- Pharmacy Practice
- Health Informatics
Background:
- Rapid evolution of smartphone and tablet technology.
- Healthcare sector's increasing adoption of new technologies.
- Emergence of mobile applications (apps) for healthcare.
Purpose of the Study:
- To assess UK registered pharmacists' views on using mobile apps in community healthcare.
- To explore perceptions of mobile app utility and barriers in pharmacy practice.
Main Methods:
- Distribution of a 30-item questionnaire to 600 UK pharmacists.
- Data collection via multiple choice, Likert scale, and open-answer questions.
- Analysis using SPSS with frequencies, cross-tabulations, and non-parametric tests.
Main Results:
- 78.4% of 211 participants were confident using mobile apps.
- Apps perceived as useful for patient consultations (55%) and healthcare education (80%).
- Company policy identified as a significant barrier, especially in chain pharmacies.
Conclusions:
- Pharmacists are generally supportive of mobile apps in healthcare.
- Risk, company policy, and lack of regulation currently limit app use.
- Addressing technological limitations is crucial for maximizing healthcare system uptake.
Related Concept Videos
01:26Drug Administration and Therapy Phases: Overview
1.9K
Drugs, the chemical agents used in diagnosing, treating, or preventing diseases, undergo a four-phase process of development: pharmaceutic, pharmacokinetics, pharmacodynamics, and therapeutic.
The pharmaceutical phase focuses on leveraging the physicochemical properties of the drug to design and manufacture an effective product. Variants include orally administered tablets or capsules, topical creams or ointments, and parenteral-delivery solutions or emulsions.
The pharmacokinetic phase...
The pharmaceutical phase focuses on leveraging the physicochemical properties of the drug to design and manufacture an effective product. Variants include orally administered tablets or capsules, topical creams or ointments, and parenteral-delivery solutions or emulsions.
The pharmacokinetic phase...
1.9K
01:26Pharmaceutical Poisoning: Potential Scenarios
116
Pharmaceutical poisoning can occur through various channels, impacting an estimated 2 million hospitalized patients in the U.S. annually with serious adverse drug responses. These scenarios encompass both therapeutic uses, such as drug toxicity, where even standard dosages can lead to severe central nervous system depression, and non-therapeutic exposures, including accidental ingestion by children, and environmental and occupational exposures.Unintentional poisonings often involve exploratory...
116
01:28Biopharmaceutics and Pharmacokinetics: Overview
4.6K
Understanding drugs, drug products, and their performance in pharmaceutical science is pivotal. Drugs, whether simple molecules or complex compounds, are designed to interact with the body's biological systems to diagnose, treat, or prevent diseases. Drug products include various delivery systems such as tablets, capsules, injections, and inhalers. The performance of these drug products is gauged by their ability to deliver the active ingredient to the desired site of action at the...
4.6K
01:29Issues And Trends In Healthcare Delivery System
6.5K
The issues and trends in healthcare delivery are constantly changing. The COVID-19 pandemic is one recent issue that wreaked havoc on healthcare systems, causing a shortage of healthcare workers, high demand for medicines and supplies, and increased medical expenditure due to a lack of insurance. Other issues include rising healthcare costs and care fragmentation.
Cost Containment
Payment for healthcare services has historically promoted adoption of costly and often unnecessary or inefficient...
Cost Containment
Payment for healthcare services has historically promoted adoption of costly and often unnecessary or inefficient...
6.5K
01:26Pharmaceutical Equivalents
270
As defined by regulatory standards, pharmaceutical equivalents require generic drug products to have identical dosage forms and chemically identical active pharmaceutical ingredients (APIs). They must adhere to compendial or applicable standards for potency, content uniformity, disintegration times, and dissolution rates. In the case of modified-release dosage forms, variations in drug content are permissible as long as the delivered amount remains consistent with the innovator drug product.
270
01:28Dosage Regimens: Designs and Approaches
594
Designing a dosage regimen, which refers to the manner of drug administration, is a complex process involving the selection of drug dose, route, and frequency. This process is underpinned by pharmacokinetic parameters derived from tests and population averages. These parameters are then tailored to patient-specific variables such as diagnosis, demographics, and allergy status. Once therapy commences, therapeutic response monitoring is critical and achieved through clinical and physical...
594